News Drug Formulary Safety Net Resources
Drug Formulary Categories and Charges Search HA Drug Formulary Self-financed Drugs Available for Purchase by Patients at HA Pharmacy How we evaluate new drugs Governance Drug Management Committee Drug Advisory Committee Drug Formulary Committee Drug & Therapeutics Committee Drug Selection Committee Expert Panel Medication Safety Committee Samaritan Fund Community Care Fund Drug Education HA Drug Formulary Management Manual Frequently Asked Questions Useful Links
HA Drug Formulary
Version 22.1 – with effect from 25 July 2026
  1. The drugs may either be listed as generic or proprietary names, where appropriate. Brand names listed serve as reference only, they do not necessarily indicate the availability of that particular brand.
  2. Some drugs may appear in more than one category due to different formulations and/or indications.
  3. The "Special" drugs will be prescribed as clinically indicated based on the specified indications.
  4. Based on operational logistics and needs, individual cluster/hospital may only stock part of the drugs listed on the HA Drug Formulary.
Drug classes
Result of:
Malignant disease & Immunosuppression
General Drugs Special Drugs Self-financed Items
with Safety Net		 Self-financed Items
without Safety Net
Malignant disease & Immunosuppression
General Drugs Special Drugs Self-financed Items
with Safety Net		 Self-financed Items
without Safety Net
CYTOTOXIC DRUGS
ACTINOMYCIN D ARSENIC TRIOXIDE ABEMACICLIB ACALABRUTINIB
ASPARAGINASE AZACITIDINE (VIDAZA) ACALABRUTINIB ALPELISIB
BLEOMYCIN BENDAMUSTINE AFATINIB ASCIMINIB
CALCIUM FOLINATE BLINATUMOMAB ALECTINIB ATEZOLIZUMAB
CAPECITABINE BUSULPHAN APALUTAMIDE BEVACIZUMAB
CARBOPLATIN CETUXIMAB ASCIMINIB BORTEZOMIB
CARMUSTINE CLADRIBINE ATEZOLIZUMAB CABOZANTINIB (CABOMETYX)
CHLORAMBUCIL CLOFARABINE AVELUMAB CAPMATINIB
CISPLATIN CRISANTASPASE (ASPARAGINASE ERW) AXITINIB CARFILZOMIB
CYCLOPHOSPHAMIDE DASATINIB AZACITIDINE (ONUREG) CETUXIMAB
CYTARABINE ERIBULIN AZACITIDINE (VIDAZA) DABRAFENIB
DACARBAZINE ERLOTINIB BELZUTIFAN DACOMITINIB
DAUNORUBICIN EVEROLIMUS (AFINITOR) (OR EQUIV) BENDAMUSTINE DOSTARLIMAB
DOCETAXEL FLUDARABINE BEVACIZUMAB DOXORUBICIN (LIPOSOMAL)
DOXORUBICIN FRUQUINTINIB BORTEZOMIB DURVALUMAB
EPIRUBICIN GEFITINIB BRENTUXIMAB VEDOTIN ENFORTUMAB VEDOTIN
ETOPOSIDE IFOSFAMIDE BRIGATINIB EPCORITAMAB
FLUOROURACIL IMATINIB CABOZANTINIB (CABOMETYX) ESTRAMUSTINE
GEMCITABINE MITOXANTRONE CARFILZOMIB EVEROLIMUS (AFINITOR) (OR EQUIV)
HYDROXYUREA PEGASPARAGINASE CETUXIMAB LENVATINIB
IDARUBICIN SORAFENIB CRIZOTINIB NIRAPARIB (TOSYLATE)
IRINOTECAN TEMOZOLOMIDE DABRAFENIB OBINUTUZUMAB
LOMUSTINE THIOTEPA DARATUMUMAB OLAPARIB
MELPHALAN TOPOTECAN DOSTARLIMAB PACLITAXEL (ALBUMIN)
MERCAPTOPURINE TRASTUZUMAB DOXORUBICIN (LIPOSOMAL) PAZOPANIB
MESNA TS-1 (OR EQUIV) DURVALUMAB PEMBROLIZUMAB
METHOTREXATE VINORELBINE ELRANATAMAB PERTUZUMAB + TRASTUZUMAB
MITOMYCIN ENCORAFENIB REGORAFENIB
MITOTANE EVEROLIMUS (AFINITOR) (OR EQUIV) SELPERCATINIB
OXALIPLATIN GEMTUZUMAB SUNITINIB
PACLITAXEL GILTERITINIB TISLELIZUMAB
PEMETREXED GLOFITAMAB TRAMETINIB
PROCARBAZINE IBRUTINIB TRASTUZUMAB DERUXTECAN
THIOGUANINE INOTUZUMAB OZOGAMICIN TRASTUZUMAB EMTANSINE
TRETINOIN IPILIMUMAB TRIFLURIDINE + TIPIRACIL
VINBLASTINE ISATUXIMAB VENETOCLAX
VINCRISTINE IXAZOMIB ZOLBETUXIMAB
LAPATINIB
LENVATINIB
LORLATINIB
MIDOSTAURIN
NERATINIB
NILOTINIB
NIRAPARIB (TOSYLATE)
NIVOLUMAB
OBINUTUZUMAB
OLAPARIB
OSIMERTINIB
PACLITAXEL (ALBUMIN)
PALBOCICLIB
PANITUMUMAB
PAZOPANIB
PEMBROLIZUMAB
PERTUZUMAB
PERTUZUMAB + TRASTUZUMAB
POLATUZUMAB VEDOTIN
PONATINIB
RIBOCICLIB
RUXOLITINIB
SACITUZUMAB GOVITECAN
SELINEXOR
SELUMETINIB
SUNITINIB
TEMOZOLOMIDE
TEPOTINIB
TORIPALIMAB
TRAMETINIB
TRASTUZUMAB
TRASTUZUMAB DERUXTECAN
TRASTUZUMAB EMTANSINE
TREMELIMUMAB
VENETOCLAX
ZANUBRUTINIB
DRUGS AFFECTING THE IMMUNE RESPONSE
AZATHIOPRINE ALEMTUZUMAB (LEMTRADA) BELUMOSUDIL LENALIDOMIDE
BCG ANTITHYMOCYTE IMMUNOGLOBULIN BENRALIZUMAB RITUXIMAB
THALIDOMIDE BASILIXIMAB CANAKINUMAB
CYCLOSPORIN A CLADRIBINE (MAVENCLAD)
CYCLOSPORIN A (NEORAL) INTERFERON GAMMA
CYCLOSPORIN A (TEVA) LENALIDOMIDE
DIMETHYL FUMARATE MEPOLIZUMAB
EVEROLIMUS (CERTICAN) (OR EQUIV) MOMELOTINIB
FINGOLIMOD POMALIDOMIDE
INTERFERON BETA RITUXIMAB
MYCOPHENOLATE SILTUXIMAB
NATALIZUMAB SIPONIMOD
OFATUMUMAB
PEGINTERFERON ALFA
RITUXIMAB
SIROLIMUS
TACROLIMUS
TERIFLUNOMIDE
SEX HORMONES AND HORMONE ANTAGONISTS IN MALIGNANT DISEASE
LETROZOLE ANASTROZOLE ABIRATERONE ABIRATERONE
MEDROXYPROGESTERONE ACETATE BICALUTAMIDE ENZALUTAMIDE DAROLUTAMIDE
MEGESTROL BUSERELIN FULVESTRANT ENZALUTAMIDE
OCTREOTIDE CYPROTERONE FULVESTRANT
SOMATOSTATIN DEGARELIX
TAMOXIFEN EXEMESTANE
FLUTAMIDE
GOSERELIN
LANREOTIDE
LEUPRORELIN
OCTREOTIDE
PASIREOTIDE
TRIPTORELIN
RADIOPHARMACEUTICALS
LUTETIUM OXODOTREOTIDE
LUTETIUM VIPIVOTIDE TETRAXETAN